Literature DB >> 18019371

Survival of trisomy 18 cases in Japan.

G Imataka1, A Nitta, H Suzumura, H Watanabe, H Yamanouchi, O Arisaka.   

Abstract

The prognosis of trisomy 18 is lethal, but recently some long-term survival cases have been recognized. We report here the mortality rate of trisomy 18 based on our hospital data and sporadically published reports in Japan. We collected the 7 previously published reports of mortality and 31 cases from our hospital data with trisomy 18. Our data pool comprised a total of 179 cases of trisomy 18 from 8 institutions. The mortality rates within 24 hours, 7, 28, 60, 180, and 365 days from birth were 14.84% (19/128), 31.01% (40/129), 56.25% (72/128), 64.08% (66/103), 82.17% (106/129), and 90.90% (140/154), respectively. Fourteen of the 154 patients (9.09%) survived for more than 1 year. The Kaplan-Meier survival curves from 78 patients of 5 institutes suggest that trisomy 18 children who have survived over 7 months after birth may have a high probability of long-term survival. We should recognize not only that about 50% of infants with trisomy 18 die within 1 month after birth, but also that about 10% of patients survive over 1 year in Japan. These findings comprise Asia's first clinical statistics concerning trisomy 18, in which the data were collected from multiple institutions. This evidence is valuable in order to perform genetic counseling concerning the natural history of trisomy 18 not only in Japan but also in other countries.

Entities:  

Mesh:

Year:  2007        PMID: 18019371

Source DB:  PubMed          Journal:  Genet Couns        ISSN: 1015-8146


  5 in total

1.  A visual tool inclusive of fetal ultrasound and autopsy findings to reach a balanced approach to counseling on trisomy 18 in early second trimester.

Authors:  Stefania Triunfo; Marta Bonollo; Priska Gaffuri; Manuela Viviano; Daniele Satta; Manuela Bergmann
Journal:  Arch Gynecol Obstet       Date:  2021-06-22       Impact factor: 2.344

Review 2.  Chromosome analysis using spectral karyotyping (SKY).

Authors:  George Imataka; Osamu Arisaka
Journal:  Cell Biochem Biophys       Date:  2012-01       Impact factor: 2.194

3.  Better prognosis in newborns with trisomy 13 who received intensive treatments: a retrospective study of 16 patients.

Authors:  Keiko Tsukada; George Imataka; Hiroshi Suzumura; Osamu Arisaka
Journal:  Cell Biochem Biophys       Date:  2012-07       Impact factor: 2.194

Review 4.  The trisomy 18 syndrome.

Authors:  Anna Cereda; John C Carey
Journal:  Orphanet J Rare Dis       Date:  2012-10-23       Impact factor: 4.123

5.  Clinical features and survival in individuals with trisomy 18: A retrospective one-center study of 44 patients who received intensive care treatments.

Authors:  George Imataka; Hiroshi Suzumura; Osamu Arisaka
Journal:  Mol Med Rep       Date:  2016-01-22       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.